Comparative Study on the MDR Reversal Effects of Selected Chalcones

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Cancer Biology

Background:

• Multidrug resistance (MDR) in cancer poses a significant challenge to chemotherapy efficacy.
• P-glycoprotein (P-gp) is a key transporter involved in MDR.
• Chalcones are a class of compounds with diverse biological activities, including potential anticancer properties.

Purpose of the Study:

• To synthesize and evaluate novel chalcone derivatives for their ability to reverse multidrug resistance.
• To investigate the in vitro interaction of potent chalcones with doxorubicin in combination chemotherapy.
• To establish structure-activity relationships for the design of new P-gp modulators.

Main Methods:

• Synthesis of fifteen chalcone derivatives based on established lead compounds.
• Assessment of MDR reversal activity in mouse lymphoma cells.
• In vitro evaluation of drug interactions using doxorubicin and human MDR1 gene-transfected mouse lymphoma cells.
• Determination of IC50 values for cell proliferation inhibition.

Main Results:

• Several synthesized chalcones exhibited significant MDR reversal activity, exceeding that of verapamil.
• Two chalcones demonstrated additive or indifferent interactions with doxorubicin in combination chemotherapy models.
• Two chalcone compounds showed potent inhibition of cell proliferation with IC50 values around 0.4 μg/mL.
• Structure-activity relationship analysis provided insights into the design of effective P-gp modulators.

Conclusions:

• Chalcone derivatives are promising candidates for overcoming multidrug resistance in cancer.
• These compounds can enhance the efficacy of existing anticancer drugs like doxorubicin.
• The structure-activity relationships identified can guide the development of novel therapeutic agents for resistant cancers.